Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
September 9, 2010
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline
Phyllis W Speiser, Ricardo Azziz, Laurence S Baskin, et al.
Journal of the Endocrine Society
|
September 16, 2022
Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function <i>LHCGR</i> Variant
Chelsi Flippo, Vipula Kolli, Melissa Andrew, et al.
European Journal of Endocrinology
|
June 27, 2025
Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules
Wiebke Arlt, Aude Brac de la Perrière, Angelica L Hirschberg, et al.
Endocrine Connections
|
June 27, 2024
Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia
Dafydd Aled Rees, Deborah P Merke, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 2, 2021
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Deborah P Merke, Ashwini Mallappa, Wiebke Arlt, et al.
Clinical Endocrinology
|
May 16, 2025
Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control
Richard John M Ross, Wiebke Arlt, Aude Brac de la Perriere, et al.
The New England Journal of Medicine
|
June 3, 2024
Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
Richard J Auchus, Oksana Hamidi, Rosario Pivonello, et al.
European Journal of Endocrinology
|
January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia
Lea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
Ebiomedicine
|
May 21, 2025
Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia
Neil R Lawrence, Jeremy Dawson, Zi-Qiang Lang, et al.
Endocrine Reviews
|
May 7, 2021
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management
Hedi L Claahsen-van der Grinten, Phyllis W Speiser, S Faisal Ahmed, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
The Journal of Clinical Endocrinology and Metabolism
|
September 9, 2010
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline
Phyllis W Speiser, Ricardo Azziz, Laurence S Baskin, et al.
Journal of the Endocrine Society
|
September 16, 2022
Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function <i>LHCGR</i> Variant
Chelsi Flippo, Vipula Kolli, Melissa Andrew, et al.
European Journal of Endocrinology
|
June 27, 2025
Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules
Wiebke Arlt, Aude Brac de la Perrière, Angelica L Hirschberg, et al.
Endocrine Connections
|
June 27, 2024
Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia
Dafydd Aled Rees, Deborah P Merke, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 2, 2021
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Deborah P Merke, Ashwini Mallappa, Wiebke Arlt, et al.
Clinical Endocrinology
|
May 16, 2025
Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control
Richard John M Ross, Wiebke Arlt, Aude Brac de la Perriere, et al.
The New England Journal of Medicine
|
June 3, 2024
Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
Richard J Auchus, Oksana Hamidi, Rosario Pivonello, et al.
European Journal of Endocrinology
|
January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia
Lea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
Ebiomedicine
|
May 21, 2025
Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia
Neil R Lawrence, Jeremy Dawson, Zi-Qiang Lang, et al.
Endocrine Reviews
|
May 7, 2021
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management
Hedi L Claahsen-van der Grinten, Phyllis W Speiser, S Faisal Ahmed, et al.
Page
of 12